Who Am I to Tell You Not to Use Drugs? | Huset Bergen – A Peer-Led Harm Reduction House in Norway | In Bergen, on Norway’s rainy western coast, Huset Bergen — a three-storey harm reduction centre — is run entirely by people with lived and living experience of drug use.
Making Psilocybin Therapy Accessible in New Mexico – Interview with Senator Jeff Steinborn
Avoiding Colonization in the Psychedelic Renaissance – In Dialogue with Charlotte James
Step inside the UK’s first legal safer drug consumption room. In Drugreporter’s new video, Lynn MacDonald, service manager at The Thistle, takes us through a space built not only for life-saving safer use, but for compassion, dignity, and respect — putting care and humanity at the center.
New interview! Communitas – Psychedelics and the Healing Power of Community - In Conversation with Leor Roseman, PhD
Psychedelics Can Provide Spiritual Validation to LGBTQI People – Interview with Jae Sevelius, PhD drogriporter.hu/en/psychedel...
Colorado is the second U.S. state to legalize the therapeutic use of psilocybin mushrooms. Drugreporter visited ETC Hospitality in Golden, Colorado to see how psilocybin-assisted psychotherapy will be practiced in real-world settings.
drogriporter.hu/en/drugrepor...
In Drugreporter's new interview, Clinical psychologist Brian Richards, Psy.D., explains how psychedelics can transform palliative care—from creating truly healing therapeutic spaces to supporting patients facing the end of life. drogriporter.hu/en/psychedel...
The Stop the Deaths conference in Glasgow brings together families, experts, lived-experience voices and policymakers to confront the overdose crisis and push for real change. Watch Drugreporter's new documentary! drogriporter.hu/en/stop-the-...
Two spiritual leaders from different faiths reveal how psychedelics are transforming their understanding of religion, community, and each other — watch Drugreporter’s new interview! drogriporter.hu/en/religion-...
In Drugreporter's new interview, trauma expert Bessel van der Kolk, MD explores how the body stores trauma and why integration is essential for healing in psychedelic therapy. drogriporter.hu/en/trauma-an...
In Drugreporter’s new interview, German author Norman Ohler explores how psychedelics became entangled with war, power, and propaganda. drogriporter.hu/en/norman-oh...
In Drugreporter’s new interview, Dominique Mendiola, Senior Director of Colorado’s Natural Medicine Division, shares how Colorado is shaping the next chapter of psychedelic regulation in the United States. drogriporter.hu/en/colorado-...
In Drugreporter’s interview from Psychedelic Science 2025, Rick Doblin looks back on four decades of psychedelic activism and discusses the future after the FDA’s MDMA therapy rejection.
It was an absolute honour to attend and film the world’s largest gathering of the psychedelic science community: Psychedelic Science 2025 in Denver, Colorado. We are grateful to the many outstanding scientists, healers, and activists who shared their wisdom with us — Watch our videos to learn more!
At ICPR 2024, we spoke with Ethan Nadelmann, founder of the Drug Policy Alliance, about how psychedelics fit into the broader landscape of drug policy reform. Note: This interview was recorded prior to the FDA’s decision to reject MDMA therapy for PTSD.
In this thought-provoking conversation, Prof. Dr. Thomas Metzinger, a leading philosopher of mind and consciousness, examines the profound potential — and serious risks — of psychedelics.
Watch three exciting book presentations that Drugreporter recorded at PS25 in Denver, by Timothy Leary’s son, Zach Leary, Wendy Tucker, Ann Shulgin’s daughter and Diego Ugalde.
At the Interdisciplinary Conference on Psychedelic Research (ICPR) 2024, we interviewed Israeli psychotherapist Nir Tadmor about how he supported survivors of the Nova festival massacre and the deep emotional impact the tragedy had on the community. drogriporter.hu/en/offering-...
"I want a UNODC that complies with the decisions of the member states." - Ambassador Laura Gil #cnd #unodc #unitednations
On the eve of her departure from her post as the Ambassador of Colombia to Austria and Permanent Representative to the United Nations in Vienna, we spoke to Ambassador Laura Gil about her time in Vienna and her achievements drogriporter.hu/en/laura-gil...
Creating supportive communities to integrate the psychedelic experience is just as important as ensuring a safe setting for the experience itself. Watch our interview with Rosalind Watts, a clinical psychologist and the founder of ACER Integration, UK! drogriporter.hu/en/community...
Psychedelics are the master keys to unlocking hidden potentials in our brains - our interview with Gül Dölen drogriporter.hu/en/what-octo...
The Funding Crisis of Harm Reduction – An Interview with Catherine Cook - At #HR25, we spoke with Catherine Cook from Harm Reduction International about the state of harm reduction funding and the global impact of U.S. foreign aid cuts under Trump. drogriporter.hu/en/the-fundi...
Drug Policy Prospects in Trump’s Second Term – An Interview with Ethan Nadelmann drogriporter.hu/en/drug-poli...
COSS MARTE: From Convict to Cannabis CEO in New York - Drugreporter’s new video about Coss Marte, a former convict who, thanks to New York State’s Social Equity Program, now runs three cannabis retail shops and a gym: drogriporter.hu/en/coss-marte/
More than a thousand harm reduction professionals gathered in Bogotá, Colombia, to attend the 28th Harm Reduction International Conference. Watch Drugreporter's recap video here!
WHEN THE ADULT IN THE ROOM IS GONE: Trump’s Budget Cuts and Global Drug Policy - The Trump administration’s slashing of foreign aid is already having a devastating impact on harm reduction and HIV services around the world. new video! drogriporter.hu/en/when-the-...
Under the pretext of fighting a war on drugs to “protect the children,” Hungarian Prime Minister Viktor Orbán is preparing a major crackdown on civil society and free speech. This could lead to harm reduction and drug policy reform being repressed—much like in Russia—including Drugreporter itself.
